Ginsburg Appointed to ACPE Board of Directors

Headshot of Dr. Diane Ginsburg.
December 11, 2023
Associate Dean for Healthcare Partnerships Dr. Diane Ginsburg was appointed to the Accreditation Council for Pharmacy Education (ACPE) Board of Directors effective July 1, 2024. ACPE is the national agency for the accreditation of professional degree programs in pharmacy and providers of continuing pharmacy education.

Popular OTC Medicines for Colds and Allergies Don’t Work, FDA Panel Says

Rows of boxes of ineffective nasal decongestants.
September 12, 2023
An independent advisory committee to the FDA has determined that phenylephrine, a popular ingredient in many over-the-counter allergy and cold medicines, is ineffective in tablet form. CNN and numerous other national news outlets quote from the College of Pharmacy's Associate Dean for Healthcare Partnerships Dr. Diane Ginsburg, who serves on the committee, regarding this decision.

Texas Pharmacy Exceeds Residency Match Placement Goals

91% Residency Match Placement. National Average: 82%. The University of Texas at Austin College of Pharmacy. American Society of Health-System Pharmacists, 2023 Pharmacy Residency Match.
May 4, 2023
The University of Texas at Austin College of Pharmacy placed in the top ten in the entire country in the percentage of match placements with 91%, compared to the national match placement average of 82%.

Vasquez Writes in Nature Reviews Genetics on Alternative DNA Structures

"Nature Reviews Genetics" written inside of a circle.
November 1, 2022
Division Head and Professor of Pharmacology & Toxicology Karen Vasquez, Ph.D. published in the latest issues of Nature Reviews Genetics regarding repetitive elements in the human genome. Once considered "junk DNA," they are now known to adopt more than a dozen alternative DNA structures. These dynamic conformations can act as functional genomic elements involved in DNA replication and transcription, chromatin organization and genome stability.

Faculty Earn State Grants for Cancer Research

A person in a lab.
September 21, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

PharmE3D Labs Earn National and International Accolades

Brick facade of Pharmacy building with affixed text, "The University of Texas at Austin College of Pharmacy"
July 11, 2022
Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.

Celebrating the Latest Awards, Appointments and Achievements from the UT Pharmacy Community

Pharmacy building on UT campus
July 5, 2022
From student scholarships to national recognition awards to prestigious appointments, the UT Pharmacy community has a lot to celebrate and be proud of right now.

Ginsburg appointed to Provost’s Distinguished Service Academy

Headshot of Dr. Diane Ginsburg.
May 5, 2022
Dr. Diane Ginsburg has been appointed to the Provost’s Distinguished Service Academy for her excellence in mentorship and demonstrated mastery across scholarship, teaching, leadership and service.

UT Pharmacy Earns Highest Residency Match Rate in Texas

#1 Residency Match Placement in Texas
April 19, 2022
Pharmacy schools across the country completed their 2022 Phase I and Phase II residency matches for new or upcoming graduates of their Doctor of Pharmacy (Pharm.D.) programs. The University of Texas at Austin College of Pharmacy placed in the top ten of all pharmacy schools in the nation, and number one in Texas.

PharmE3D Labs Receive Federal Funding for 3D Printed Contraception

Four people wearing masks and lab coats.
March 14, 2022
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.